This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Shanghai Bocimed Pharmaceutical Co., Ltd., Shanghai Bocimed Pharmaceutical Co., Ltd., Shanghai Yonsun Biotechnology Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Zhixiang Chen: Innovator in Pharmaceutical Composition
Introduction: Zhixiang Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy and delivery of pharmaceutical compounds.
Latest Patents: Zhixiang Chen holds a patent for a fulvestrant pharmaceutical composition, which includes a preparation method and its applications. This composition features fulvestrant solid particles with specific particle size distributions, ensuring a long-acting sustained release. The patent outlines that the particle sizes are carefully selected, with Dv(10) ranging from 0.400 micrometers to 6.000 micrometers, Dv(50) from 0.700 micrometers to 6.000 micrometers, and Dv(90) from 1.000 micrometers to 6.000 micrometers, while adhering to specific conditions regarding these values.
Career Highlights: Zhixiang Chen is currently employed at Shanghai Bocimed Pharmaceutical Co., Ltd. His role at the company allows him to apply his expertise in pharmaceutical development and contribute to innovative solutions in the healthcare sector. His work has been instrumental in advancing drug formulations that improve patient outcomes.
Collaborations: Zhixiang Chen collaborates with notable colleagues, including Shuhuan Ying and Hong Li. Their combined efforts in research and development have led to significant advancements in pharmaceutical technologies.
Conclusion: Zhixiang Chen's contributions to the field of pharmaceuticals, particularly through his innovative patent on fulvestrant compositions, highlight his role as a key inventor in the industry. His work continues to influence the development of effective drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile